Renaissance Technologies’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$33.4M Buy
1,547,732
+70,699
+5% +$1.52M 0.04% 496
2025
Q1
$24.5M Buy
1,477,033
+250,500
+20% +$4.16M 0.04% 583
2024
Q4
$22.5M Buy
1,226,533
+823,333
+204% +$15.1M 0.03% 613
2024
Q3
$6.2M Sell
403,200
-72,800
-15% -$1.12M 0.01% 1308
2024
Q2
$7.74M Sell
476,000
-97,800
-17% -$1.59M 0.01% 1068
2024
Q1
$10.6M Buy
573,800
+389,800
+212% +$7.21M 0.02% 962
2023
Q4
$5.76M Buy
+184,000
New +$5.76M 0.01% 1267
2023
Q3
Sell
-130,800
Closed -$3.13M 3615
2023
Q2
$3.13M Buy
130,800
+13,000
+11% +$311K ﹤0.01% 1705
2023
Q1
$2.22M Sell
117,800
-197,900
-63% -$3.72M ﹤0.01% 1970
2022
Q4
$5.03M Buy
315,700
+278,000
+737% +$4.43M 0.01% 1520
2022
Q3
$617K Buy
+37,700
New +$617K ﹤0.01% 2800
2022
Q2
Sell
-14,500
Closed -$351K 4177
2022
Q1
$351K Buy
+14,500
New +$351K ﹤0.01% 3395
2021
Q2
Sell
-581,000
Closed -$15M 3413
2021
Q1
$15M Buy
581,000
+398,600
+219% +$10.3M 0.02% 946
2020
Q4
$9.75M Sell
182,400
-87,100
-32% -$4.66M 0.01% 1189
2020
Q3
$11.1M Buy
269,500
+157,300
+140% +$6.49M 0.01% 1062
2020
Q2
$5.44M Buy
112,200
+51,400
+85% +$2.49M ﹤0.01% 1595
2020
Q1
$2.57M Sell
60,800
-670,200
-92% -$28.3M ﹤0.01% 1925
2019
Q4
$31.3M Buy
731,000
+645,200
+752% +$27.6M 0.02% 756
2019
Q3
$3.09M Buy
+85,800
New +$3.09M ﹤0.01% 2049
2019
Q1
Sell
-597,800
Closed -$9.67M 3420
2018
Q4
$9.67M Buy
597,800
+425,500
+247% +$6.88M 0.01% 1328
2018
Q3
$3.58M Sell
172,300
-50,900
-23% -$1.06M ﹤0.01% 1996
2018
Q2
$3.41M Buy
+223,200
New +$3.41M ﹤0.01% 1999